Cargando…
Transcriptome Analysis of Mesenchymal Stem Cells from Multiple Myeloma Patients Reveals Downregulation of Genes Involved in Cell Cycle Progression, Immune Response, and Bone Metabolism
A growing body of evidence suggests a key role of tumor microenvironment, especially for bone marrow mesenchymal stem cells (MSC), in the maintenance and progression of multiple myeloma (MM), through direct and indirect interactions with tumor plasma cells. Thus, this study aimed to investigate the...
Autores principales: | Fernando, Rodrigo Carlini, Mazzotti, Diego Robles, Azevedo, Hatylas, Sandes, Alex Freire, Rizzatti, Edgar Gil, de Oliveira, Mariana Bleker, Alves, Veruska Lia Fook, Eugênio, Angela Isabel Pereira, de Carvalho, Fabrício, Dalboni, Maria Aparecida, Martins, David Correa, Colleoni, Gisele Wally Braga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355867/ https://www.ncbi.nlm.nih.gov/pubmed/30705326 http://dx.doi.org/10.1038/s41598-018-38314-8 |
Ejemplares similares
-
Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma
por: Eugênio, Angela Isabel Pereira, et al.
Publicado: (2017) -
Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2021) -
Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2015) -
FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells
por: Braga, Walter Moises Tobias, et al.
Publicado: (2014) -
Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)